What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
The available NIH notices do not establish that NIH has revived the Centers for Research in Emerging Infectious Diseases (CREID) Network, or that a revived program has new restrictions baffling scientists. NIH’s documented CREID funding opportunity is an expired 2024 notice. STAT reported in June 2026 that the network’s grants were terminated in 2025. Separate NIH policies issued or proposed in 2026 address high-risk life-sciences research and biosafety, but the available notices do not connect them to a CREID relaunch.
What was the CREID Network?
The Centers for Research in Emerging Infectious Diseases Network was designed as a collaboration of research teams in the United States and other countries. NIAID said it established the network in 2020; in its 2024 funding notice, it described CREID as comprising ten research centers and one coordination center.
As an Amazon Associate I earn from qualifying purchases.
The network’s purpose was to improve understanding of emerging and re-emerging infectious diseases, strengthen research capacity and readiness, and support outbreak-related research. Its proposed One Health approach connected human, animal, and environmental health.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →What the 2024 opportunity proposed
NIAID’s 2024 notice invited applications for research centers and a coordination center, with an application deadline in June 2024. It anticipated work including pathogen discovery and surveillance, transmission, disease presentation and immune response, emergence-risk modeling, diagnostics, animal models, and research foundational to medical countermeasures. It also called for collaboration and information sharing across the network and with outside partners. Those were the design and expectations in that funding opportunity, not confirmation of current CREID activities.
#1 Best Overall
Did NIH restart the network?
The documented 2024 NIAID opportunity is expired, and it does not announce a new award round or relaunch. STAT reported in June 2026 that CREID grants were terminated in 2025 amid cuts to work related to COVID-19 and pandemic preparedness. The available material therefore supports the history of the network and the reported termination, but does not verify a restart or its terms.
STAT also reported that researchers involved in CREID said the cuts weakened international relationships built over years to streamline outbreak research and the development of diagnostics and treatments. CREID was not described as a frontline outbreak-response organization like CDC or USAID; its role was research coordination and readiness.
For the program’s funding, STAT attributed figures to Grant Witness data: $82 million allocated over five years and $14.9 million remaining unspent. These are figures reported by STAT from Grant Witness, not figures attributed here directly to NIH.
What are the documented NIH research restrictions?
Two NIH policy developments in 2026 provide context, but neither notice establishes that its provisions are the new rules for a revived CREID Network.
Rank #3
- Avery publishing group
- Language: english
- Book - prevent and reverse heart disease: the revolutionary, scientifically proven, nutrition-based cure
July 28, 2026: high-risk life-sciences research policy
NIH’s July 28 notice describes the U.S. Government Policy for Stopping High-Risk Life Sciences Research. It says activities identified as potential dangerous gain-of-function research under earlier notices remain paused until NIH establishes its specific implementation requirements. It identifies dangerous gain-of-function research and international research of concern as high-risk categories and describes prohibitions on federal support. The notice also sets timelines for agencies to publish implementation guidance and establish an independent review body.
August 19, 2026: proposed NIH biosafety policy
NIH’s August 19 notice sought comments on a draft Biosafety Policy for Research Involving Biohazards. The proposal would broaden oversight to laboratory biomedical research involving biohazards and, if finalized, replace the existing NIH Guidelines. NIH described a risk-based review process under which some higher-risk research would require approval from both NIH and an institutional biosafety committee. The notice was a proposal, not a final policy; comments were due October 19, 2026.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Are scientists baffled by restrictions on a revived CREID?
The available notices do not establish which restrictions scientists reportedly find baffling, and they contain no verified, attributable statements from named scientists about new CREID rules. Nor do they establish that either the government-wide high-risk research policy or NIH’s draft biosafety policy applies as a specific condition of a CREID relaunch. Treating those policies as the network’s new restrictions would go beyond what the notices say.
To assess a claimed revival, the key evidence would be an NIH or NIAID announcement, funding notice, or award record stating whether CREID is active again and setting out its scope, eligibility, participating geography, oversight requirements, funding period, and amounts. Any account of scientists’ objections would also need direct, attributable statements identifying the provisions they oppose or find unclear.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
